34 results on '"Colalillo, Amalia"'
Search Results
2. Type 2 cytokines and scleroderma interstitial lung disease
3. Role of kinurenic acid in the systemic sclerosis renal involvement
4. Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
5. In systemic sclerosis TAPSE/sPAP ratio is correlated with ventilatory efficiency and exercise capacity assessed by CPET
6. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis
7. Serum-soluble ST2 and systemic sclerosis arthropathy
8. GLIM-diagnosed malnutrition predicts mortality and risk of hospitalization in systemic sclerosis: A retrospective study
9. Serum kynurenic acid is lower in systemic sclerosis patients with microvascular damage of hands
10. The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort
11. Phase angle, nutritional status, and mortality in systemic sclerosis: An exploratory pilot study
12. Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
13. Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis
14. DLco and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of systemic sclerosis patients
15. #2421 Kidney injury in scleroderma: serum level of fibroblast growth factor-23, klotho and neutrophil gelatinase-associated lipocalin after iloprost infusion
16. Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients
17. Reciprocal effects of scleroderma and temporomandibular dysfunction between patient cohorts.
18. Color Doppler Ultrasonography of digital arteries and digital ulcers development in systemic sclerosis
19. In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement
20. Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients
21. In Systemic Sclerosis Patients, Peripheral Blood CD21 low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement.
22. Role of kinurenic acid in the systemic sclerosis renal involvement
23. Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis
24. Serum-soluble ST2 and systemic sclerosis arthropathy
25. The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients
26. Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
27. Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis
28. In systemic sclerosis TAPSE/sPAP ratio is correlated with ventilatory efficiency and exercise capacity assessed by CPET
29. Reciprocal effects of scleroderma and temporomandibular dysfunction between patient cohorts
30. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis
31. Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis
32. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
33. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis
34. Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.